Advertisement
The first transmission of the Ebola virus in Congo's major city of Goma was announced Thursday by the country's health ministry. It said that the disease has been confirmed in the 1-year-old daughter of a man who died of Ebola on Wednesday. The man had symptoms for several days while at home with his large family

First Ebola Transmission in Congo City of Goma Reported

0
Rwanda has closed its border with Congo due to the Ebola outbreak
Compared with placebo

Oral Semaglutide Reduces HbA1c, Weight in Patients With T2DM

0
Semaglutide has a safety and tolerability profile consistent with other GLP-1 receptor agonists
Patients receiving gastric acid inhibitors have an increase in prescriptions of anti-allergic drugs

Risk for Allergy Development Increased After Gastric Acid Inhibitor Use

0
Rates ratios increased with increasing age and were more prominent in women
For patients with moderate-to-severe psoriasis

Biologic Tx for Psoriasis May Reduce Coronary Inflammation

0
Findings indicated by perivascular fat attenuation index, as measured by coronary CT angiography
Workplace injuries severe enough to warrant more than a week away from work may increase the risk for death among workers

Work-Related Injuries Up Suicide and Drug-Related Death

0
Suicide and drug-related mortality higher in both male and female injured workers
Initiation of therapy with sodium-glucose cotransporter-2 inhibitors for type 2 diabetes mellitus is not associated with an increased risk for urinary tract infection events compared with initiation of other second-line antidiabetic medications

SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events

0
Findings seen in propensity-matched cohorts versus receipt of DPP-4 inhibitors or GLP-1 agonists
Tighter rules on opioid painkiller prescriptions for U.S. government employees will be implemented in the fall

New Opioid Rx Rules Coming for U.S. Employees’ Health Plans

0
New Federal Employee Health Benefits Program rules are meant to prevent overprescribing
Three drug companies will pay a total of nearly $70 million to California to settle charges of delaying the sale of generic drugs to keep brand-name drug prices high

$70 Million Settlement Reached in Generic Drug Delay Case

0
In pay-to-delay deals, generic drug makers paid to keep cheaper version of the drug off market
Since 2008

Opioid Prescribing, New Persistent Use Down After Childbirth

0
Strongest modifiable factor linked to new persistent use after delivery was filling Rx before delivery
Its extremely high price tag means that a lifesaving medication to treat young children with spinal muscular atrophy is simply too expensive for most families.

Lifesaving Drug for Infants Costs $2.1 Million a Dose

0
When Zolgensma was approved, maker Novartis said it expected insurance companies to cover the cost